Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX

State Street Corp's stake in Biocryst Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G)

Event Mar 31, 2026 · Filed May 12, 2026

State Street Corp's stake in Biocryst Pharmaceuticals, Inc. fell to 4.90%, 12,208,360 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).

Stake
4.90%
Shares
12,208,360
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION4.90%12,208,360

Source

View original at SEC

Related